{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320262295552.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/0165-2478(96)02569-2"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:0165247896025692?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:0165247896025692?httpAccept=text/plain"}},{"identifier":{"@type":"NAID","@value":"30002646915"}}],"dc:title":[{"@value":"In vitro immunopharmacologic effect of suramin on modifying Th-subset cytokine levels in splenocytes and T-cell clones: a therapeutic application for autoimmune disease"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670320262295552","@type":"Researcher","foaf:name":[{"@value":"Philipp Novales-Li"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01652478"}],"prism:publicationName":[{"@value":"Immunology Letters"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"1996-07","prism:volume":"51","prism:number":"3","prism:startingPage":"169","prism:endingPage":"173"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:0165247896025692?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:0165247896025692?httpAccept=text/plain"}],"createdAt":"2002-07-25","modifiedAt":"2023-04-09","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390282680081491840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Suppression of Myocardial Inflammation Using Suramin, A Growth Factor Blocker."}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/0165-2478(96)02569-2"},{"@type":"CIA","@value":"30002646915"},{"@type":"CROSSREF","@value":"10.1253/circj.66.385_references_DOI_84cQRMDuOCxffamuOfhgHJv4euH"}]}